Sangamo Therapeutics (SGMO) Misses Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
EPS Growth %: +25.0%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +25.0%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q3 EPS of ($0.59), $0.27 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.39 million versus the consensus estimate of $9.36 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
